Cart
sales@molnova.com
Home - Products - Angiogenesis - Adrenergic Receptor - Brimonidine

Brimonidine

CAS No. 59803-98-4

Brimonidine ( AGN 190342; AGN-190342; AGN190342; Bromoxidine )

Catalog No. M27233 CAS No. 59803-98-4

Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P. It is used to treat open-angle glaucoma or ocular hypertension

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 80 In Stock
25MG 165 In Stock
50MG 320 In Stock
100MG 476 In Stock
500MG 1062 In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Brimonidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P. It is used to treat open-angle glaucoma or ocular hypertension
  • Description
    Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P. It is used to treat open-angle glaucoma or ocular hypertension(In Vitro):[3H]Brimonidine is a full agonist at alpha 2-adrenergic receptors labeling at least 2 specific binding sites in the human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site .
  • Synonyms
    AGN 190342; AGN-190342; AGN190342; Bromoxidine
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    5-HT Receptor; GlyT2; P2X Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59803-98-4
  • Formula Weight
    292.1
  • Molecular Formula
    C11H10BrN5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Brc1c(NC2=NCCN2)ccc2nccnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oh J, et al. Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study. J Clin Pharmacol. 2018 Jan;58(1):64-73.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products
Sign In Join Free